, which is known to reduce lytic cycle replication, eliminated mtSSB association with Zta. The predominantly mitochondrial localization of mtSSB was shifted to partly nuclear in cells expressing Zta. Mitochondrial DNA synthesis and genome copy number were reduced by Zta-induced EBV lytic replication. We conclude that Zta interaction with mtSSB serves the dual function of facilitating viral and blocking mitochondrial DNA replication.
INTRODUCTION

Epstein-Barr virus (EBV) is a human lymphotropic gammaherpesvirus that infects over
90% of the adult population world-wide (reviewed in (24, 41) ). Despite its prevalence among healthy individuals, EBV is a potent growth transforming virus that has been linked to several epithelial and lymphoid cell malignancies, including Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin's disease, gastric carcinoma, post-transplant lymphoproliferative disease and AIDS-associated non-Hodgkin's lymphomas (26, 53) . Upon primary infection of Blymphocytes EBV establishes a highly successful latency program that drives B-cell proliferation and ultimately evades immune detection (48, 49) . Productive, lytic infection occurs in terminally differentiating plasma B-cells, and in some epithelial cells. Long-term survival of the virus requires a complex interplay between latent and lytic infections, and both life cycles contribute to viral-associated disease.
Lytic cycle replication and associated gene products may contribute directly and indirectly to EBV pathogenesis. Lytic infection is observed at high rates in oral hairy leukoplakia and in EBV-positive gastric carcinoma (19, 22, 29) . Elevated levels of EBV lytic antigens is a prognostic risk factor for nasopharyngeal carcinoma (NPC) in endemic regions (13) . Lytic cycle gene expression or replication is also required for lymphomagenesis in SCID mouse models (20, 21) . EBV encodes numerous viral genes during lytic infection that have potential to alter cell physiology and host-immune response, but the precise role of these gene products in viral disease has not been characterized completely.
EBV encodes two immediate early proteins, Zta and Rta, that are essential for lytic replication (10, 11) . Viruses lacking Zta are incapable of lytic cycle gene expression or DNA replication, indicating that Zta is essential for virus viability (16) . Zta (also referred to as
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Wiedmer et al., REVISED 4 BZLF1, ZEBRA, EB1) is a member of the basic leucine zipper (b-zip) family of DNA binding proteins with sequence similarity to C/EBP, c-jun, and c-fos (27) . Despite Zta's simple structure, it has multiple functions in the EBV life cycle. Zta binds multiple recognition sites, including AP-1 and C/EBP recognition sites, and activates transcription of both viral and cellular genes (8, 23, 34, 35) . Zta functions as a DNA-bound transcription activator that can recruit cellular general transcription factors and coactivators to target promoters through an amino terminal activation domain (14) . Zta also functions as a lytic cycle replication factor by recruiting viral replication proteins to the origin of lytic replication (OriLyt) (32, 33, 45) . Zta has a profound effect on cellular gene expression and cell cycle progression. It activates transcription of cellular genes TGF- (8) and fatty acid synthase (31) through direct interaction with promoter sequences.
Zta can also bind to several key regulatory proteins, including p53, NF-kB, and c-myb, and can disrupt PML-associated nuclear domains 10 (ND10/PODs) (1, 4) . Zta also induces a cell cycle arrest through a mechanism that require its b-Zip domain, independent of its transcription activation function (7, 9, 42) .
In an effort to better understand the multiple functions of Zta during lytic infection, we isolated Zta as a multiprotein complex from cells undergoing lytic replication. We identified several cellular proteins that associate with Zta, including two proteins typically associated with mitochondrial functions. We present evidence that the mitochondrial single stranded DNA binding protein is a Zta-associated protein that facilitates EBV lytic replication and serves as a target for EBV to subvert mitochondrial DNA replication. 293 cells were grown in DMEM with 10% FBS. 3xFLAG-Zta was generated by inserting Zta cDNA as a HinDIII-BamHI fragment into p3XFLAG-myc-CMV24 vector (Sigma) for mammalian cell expression. FLAG-Zta C189S was described previously (50) . mtSSB was cloned into the ApaI-HinDIII of pRc-CMV, and was a gift from V. Tiranti and M. Zeviani.
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MATERIALS AND METHODS
Cells and
Protein purification. ZKO-293 cells were grown to 50 dishes (25 cm) and then transfected with 500 µg (10 µg/plate) expression plasmid for Zta (pCMV-FLAG-Zta) or control vector (pFLAG3x-CMV) by lipofectamine. Cells were harvested 48 hrs post-transfection by cell scraping, washed 2x with ice cold PBS twice, transferred to hypotonic buffer A (10 mH HEPES, pH. 7.9; 10 mM KCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and protease inhibitor cocktail II (Sigma)), and subject to 10 strokes of a Dounce homogenizer to isolate nuclei. The nuclei were pelleted by centrifugation at 5,000 RPM for 10 min in a Sorval SS34 rotor. Nuclei were then resuspended in Buffer B (10 mM HEPES, pH 7.9, 400 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and protease inhibitor cocktail) using a Dounce homogenizer (B pestle) to resuspend nucei. Nuclei were stirred for 30 min in Buffer B and then pelleted by centrifugation at 25,000 K for 30 min in a Sorvall SS34 rotor. The supernatant was designated
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the soluble nuclear fraction. The residual nuclear pellet was then resuspended in Buffer E (10 mM Tris pH 7.5, 10% glycerol, 400 mM NaCl, .05% IPEGAL, 1 mM DTT, mM PMSF, and protease inhibitor cocktail). The nuclear pellet was subject to sonication for 10 minutes in Bronson Sonicator until the bulk of the pellet was solubilized. The insoluble residual material was pelleted by centrifugation at 10,000 rpm for 10 min, and the remaining solubilized nuclear pellet was used for immunopurification using FLAG-Agarose (Sigma). The extract was incubated with FLAG-agarose beads (10 µl/mg of extract) overnight (~16 hrs) at 4°C and then subject to four washes with Buffer E, and one wash with Buffer C. The FLAG-agarose was then incubated with 1 column volume of Buffer C containing 1mg/ml of FLAG peptide. Eluted material was either subject to Western blot or concentrated by TCA precipitation and subject to SDS-PAGE and colloidal blue staining for analysis by mass spectrometry.
Immunoprecipitation Assays. Cell lysates were generated by incubating cells in NET buffer (10 mM Tris (pH 7.5), 150 mM NaCl, .05% NP40, 1 mM PMSF, and protease inhibitor cocktail (Sigma)) at 4°C for 30 min with gentle agitation. The nuclei were pelleted at 15,000 rpm in a microfuge centrifuge at 4°C, and the supernatant was subject to a preclearing with protein-A or protein-G sepharose for 4 hrs, and then incubated with primary antibody for 4 hrs followed by addition of protein-A (rabbit antibodies) or protein-G (mouse antibodies)-sepharose for 1 hr.
The immune complex was washed 3x with NET buffer and 1x with PBS followed by elution with SDS-PAGE and heating at 95°C for 5 min.
Immunofluorescence Assays. D98/HR1 cells were plated on glass slides and then transfected with Zta expression vector and assayed by IF as described previously (14) . Forty-eight hrs post-
transfection the cells were fixed with paraformaldehyde and washed with PBS prior to addition of primary antibody (1:500-1:1000) followed by wash 2x with PBS containing .05% Ipegal, and 2x with PBS. Fluorescent tagged secondary antibodies (FITC-linked anti-rabbit and Texas Redlinked anti-mouse).
siRNA Depletion. siRNAs for m(2)tSSB were purchased from Dharmacon as a Smartpool (#L-021365-01), and as a single siRNA targeting the following sequence: guacuucgucaguuuguaauu. siRNAs were transfected using Dharmacon transfection reagent as recommended by the manufacturer.
BrdU Incorporation Assay. BrdU incorporation into DNA was performed and quantified essentially as described (6) . Cells (5x10 5 ) were pulse labeled with 50 mM BrdU for 30 min.
DNA was then extracted by incubating cell pellets in DNA lysis buffer (50 mM Tris-Cl, pH 8.0; 1 M NaCl, 10 mM EDTA, 0.5 % SDS, 0.2 mg/ml protease K, sonicated salmon sperm DNA (0.3 mg/ml final)) at 50°C for 2 hr, extracted with phenol:chloroform, and precipitated with ethanol.
The DNA was dissolved in 500 ml TE and sonicated to an average length of ~700 bp. DNA was then heat denatured at 95 ºC for 5 min and cooled rapidly on ice. 50 µl was kept as input. 50 µl 10xIP buffer (100 mM NaPO4 (pH 7.0); 1.4 M NaCl; 0.5 % Triton X-100) was added to the DNA to make to final 1X. Then 4ul anti-BrdU (stock 25 µg/ml, BD Pharmingen) was incubated with the solution for 60min at RT with rotation. Then 3.5 µg (10 µl) rabbit anti-mouse IgG 
EBV Genome Copy Number Assay
Cells (~1 x 10 6 cells per sample) were collected and resuspended in 100 µl ChIP SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.0.). After brief sonication, ChIP IP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris pH 8.0, 167 mM NaCl) was added to 1 ml, then incubated with Proteinase K for 2-3hrs at 50 ºC. 300 µl was removed and subject to phenol/choloroform extraction and ethanol precipitation. Precipitated DNA was then assayed by real-time PCR using primers for DS region of EBV and for cellular actin DNA using a standard curve method for quantification of each DNA. The relative copy number of EBV was determined by dividing DS DNA to that of Actin DNA.
Mitochondrial DNA analysis. Total genomic DNA was isolated using SDS lysis buffer and Proteinase K for 2-3 hrs at 50°C. DNA was recovered by phenol/chloroform extraction and ethanol precipitation. RNA was then removed by RNase (DNAse free grade). Purified DNA was then digested with XmaI and analyzed by 0.8% agarose gel electrophoresis and Southern blotting. The probe for mitochondrial DNA was amplified with primers oPL2323
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(caccattagcacccaaagct) and oPL2325 (acatagcggttgttgatggg). The same primers were used for quantitative PCR analysis of mitochondrial DNA using real-time PCR. Cellular Alu DNA was identified using a single primer oPL1824 (cggagtctcgctctgtcgcccaggctggagtgcagtggcgcga).
EBV DNA was identified using the OriLyt sequence amplified by the primers oPL2095 (ccggct gggaggtgtgcaccccccgag) and oPL2096 (tctagcccctcctcctctcgttatccc). Oligonucleotides were labeled with digoxigenin using the Oligonucleotide Labeling Kit (Roche, Inc) according to manufacturers protocol.
Additional methods. EBV lytic replication was measured by real-time PCR of viral DNA relative to cellular actin DNA as described previously (50) . EMSA, luciferase assays and reporter plasmids were described previously (50) . The oligonucleotide used for single strand DNA binding in EMSA and GST-pull down assay was derived from the OriLyt upstream element (tctctgtgtaatactttaaggtttgctcaggag).
RESULTS
Identification of Zta-associated proteins. To identify cellular proteins that interact with Zta
under conditions known to cause lytic replication, we transiently expressed an epitope tagged Zta in 293 cells carrying a stable EBV genome lacking Zta (ZKO-293 cells). Zta with an aminoterminal 3XFLAG epitope was expressed to high-levels in over 80% of the cell population, and robust activation of lytic antigens EA-D and Rta were detected by Western blot analysis (data not shown). Nuclear extracts were prepared from transfected cells. We found that most of Zta remained in the nuclear pellet (data not shown). The nuclear pellet was redissolved buffer containing non-ionic detergent (.05% Ipegal) and then subject to sonication to disrupt the
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chromatin bound forms of Zta. The resolubilized Zta was then subject to immunoaffinity purification using anti-FLAG agarose and FLAG-peptide elution. Untransfected control cells were treated identically. The peptide-eluted proteins were then assayed by SDS-PAGE and visualized by colloidal blue staining (Fig. 1A) . The major bands unique to FLAG-Zta were excised and identified by mass spectrometry using LC/MS/MS. We identified several prominent proteins including three members of the HSP70 family (HSP70, Mortalin, GSAS), RNA binding proteins (hnRNPC, PABPC4), histone subunits, and several single stranded DNA binding proteins (Ku70, RPA1, RPA3, mtSSB) (Fig. 1B) . The single stranded DNA binding proteins RPA1, RPA3, and mtSSB were confirmed by Western blot analysis to be highly specific for FLAG-Zta relative to untransfected control extracts (Fig. 1C) .
Endogenous Zta associates with mtSSB. We were intrigued by the fact that mitochondrial proteins mtSSB and mitochondrial HSP70 member Mortalin were associated with Zta when isolated from nuclear pellet fractions. We therefore asked whether mtSSB associates with endogenous Zta in EBV infected B-cell lines during reactivation (Fig. 2) . Nuclear extracts were generated from an EBV positive Burkitt lymphoma cell line (MutuI) and from an EBV transformed lymphoblastoid cell line (LCL) before and after reactivation was induced by phorbol ester (TPA) and sodium butyrate (NaB). The lysates were subject to immunoprecipitation with antibody specific for Zta or control IgG, and then assayed by Western blot with antibody to Zta (top panel) or mtSSB (lower panel). As expected, Zta was highly induced after treatment with TPA and NaB, and was efficiently precipitated with Zta antibody (Fig. 2A, top panel) . We also found that mtSSB was efficiently co-immunoprecipitated with Zta from extracts where lytic
infection was induced (lane 6). A similar co-immunoprecipitation of mtSSB with Zta was observed in EBV-positive LCLs (Fig. 2B) .
mtSSB depletion reduces lytic replication. To determine if the association between mtSSB and Zta was functionally relevant, we depleted mtSSB by siRNA transfection in ZKO-293 cells.
Depletion of mtSSB was monitored by Western blot analysis and found to be reduced by ~70% (Fig. 3A) . Depletion of mtSSB had no detectable effect on cell viability or proliferation (data not (Fig. 3C) . We found that si-mtSSB caused a slight reduction in EA-D expression relative to si-Control, consistent with a reduction in lytic replication. However, the relatively small reduction in EA-D expression suggests that mtSSB was not contributing significantly to the transcription activation function of Zta .
Genetic and functional evidence for mtSSB function in EBV lytic replication. The role of mtSSB on lytic replication was further investigated by genetic analysis. A cysteine substitution mutation in the Zta basic region (C189S) has been characterized previously (51) . Zta C189S is defective for viral reactivation, but can otherwise stimulate transcription of viral promoters on transiently transfected DNA. The molecular basis for this defect was shown to be the inability of Zta C189S to recognize C/EBP binding sites, but additional deficiencies may also contribute to
the inability to activate lytic replication. We therefore compared the ability of Zta wt and C189S
to co-immunoprecipitate with mtSSB (Fig. 4A) . We found that mtSSB co-immunoprecipitated efficiently with Zta wt, but was not detectable in the immunoprecipitates with Zta C189S. The replication of Zta wt and C189S were assayed in these ZKO-293 cells (Fig. 4B) . Consistent with previous findings, Zta wt induced lytic replication (~20 fold) while Zta C189S was incapable of stimulating lytic replication more than 2 fold. When mtSSB was cotransfected with Zta wt, we found a super-activation of lytic replication by an additional 4-fold. In contrast, mtSSB had no effect on viral lytic replication in the absence of Zta or with Zta C189S. These findings suggest that mtSSB requires C189S for stable interaction with Zta, and that its overexpresssion enhances lytic replication.
To determine if some of these effects on replication were a consequence of changes in Zta transcription function, we assayed Zta transcription activation function directly. Zta transcription activity was measured using luciferase reporter plasmids in EBV negative 293 cells (Fig. 5) . We tested the affect of mtSSB on Zta transcription activation of the BMLF1 (Mp-Luc) and BHLF1 (Hp-Luc) gene promoters. We found that addition of mtSSB inhibited Zta transcription activation of both Mp-Luc and Hp-Luc by ~3 fold. This inhibition was partly explained by a reduction in Zta expression levels when mtSSB was contransfected (Fig. 5C ).
Nevertheless, these findings suggest that mtSSB does not significantly enhance, and may even inhibit Zta transcription activity. Thus, the stimulation of lytic replication by mtSSB is not an indirect result of Zta transcription activation.
Single stranded DNA enhances the interaction between mtSSB and Zta. To test the possibility that single stranded DNA may contribute to the interaction between mtSSB and Zta,
we examined the interaction with proteins expressed and purified from E. coli. GST-mtSSB and GST proteins were purified to near homogeneity (Fig. 6A) . These proteins were incubated with highly purified Zta-wt or Zta-C189S and then assayed for their ability to bind using the GST-pull down assay with glutathione sepharose beads (Fig. 6B) . We found that Zta-wt bound to GSTmtSSB weakly, but detectably in the absence of any exogenous DNA (Fig. 6B, top panel, lane   6 ). Addition of 1 pmole of a 33 bp single stranded oligonucleotide derived from EBV OriLyt region greatly facilitated the interaction between mtSSB and Zta-wt (Fig. 6B, top panel, lane 3) .
No interaction between Zta and GST was observed. Similarly, Zta-C189S did not interact with mtSSB in the absence or presence of single strand oligonucleotide DNA (Fig. 6B, lower panel) .
This suggests that the defect in C189S is in the ability to interact with mtSSB and single strand DNA. To examine the single stranded DNA binding properties of Zta more directly, we assayed Zta-wt and Zta-C189S for their ability to bind either double stranded DNA (Fig. 6C ) or single stranded DNA (Fig. 6D ) using EMSA. We found that Zta-wt and C189S bound to a double strand AP1 consensus binding site indistinguishably (Fig. 6C) . mtSSB did not bind to double stranded DNA and had no effect on Zta wt or C189S binding to double stranded DNA. In contrast, mtSSB bound to a single stranded 33 bp oligonucleotide probe derived from EBV OriLyt region (Fig. 6D) . Furthermore, Zta-wt bound significantly more (~5 fold) single stranded DNA than did C189S. Addition of mtSSB stimulated Zta-wt and C189S binding to single stranded DNA, but this stimulation was only additive and not synergistic (Fig. 6D ). These findings indicate that Zta-wt has significantly higher single stranded DNA binding capacity than does the C189S mutant, and that this difference accounts for its ability to interact preferentially with mtSSB.
Zta induces nuclear localization of mtSSB. Since mtSSB and Zta are in thought to be in different subcellular compartments, we examined the localization of these two proteins in intact cells using indirect immunofluorescence and confocal microscopy ( Fig. 7) . FLAG-Zta was transfected into EBV positive adherent cell line D98/HR1 and then visualized with a mouse monoclonal antibody to FLAG and mtSSB was visualized with a rabbit polyclonal antibody to mtSSB. We found that mtSSB was predominantly cytoplasmic in untransfected cells, with some punctate staining likely to represent mitochondria. Zta was expressed predominantly in the nuclear compartment, although some cytoplasmic staining was observed. At low resolution, it was apparent that a percentage of Zta and mtSSB colocalized, mostly at perinuclear and nuclear patches ( Fig. 7A) . At higher resolution using confocal microscopy, we observed an increase in mtSSB in the nuclei of Zta transfected cells, and substantial colocalization within the nuclear compartment ( Fig. 7B and C) . Based on these representative images, we conclude that Zta induces the mtSSB to enter the nuclear compartment, and that some Zta protein colocalizes with mtSSB in the cytoplasm.
Lytic infection inhibits mitochondrial DNA replication. The relocalization of mtSSB to the nuclear compartment suggests that mitochondrial DNA replication or genome stability may be altered by Zta and EBV lytic replication. To test the effect of Zta expression on DNA replication, we assayed BrdU incorporation for EBV, cellular DNA, and mitochondrial DNA before and after Zta expression in ZKO-293 cells (Fig. 8 ). Cells were transfected with Zta or control expression plasmid, and then pulse labeled with BrdU at 48 hrs post transfection. BrdU incorporation in DNA was then determined by immunoprecipitation with BrdU-specific antibody and real time PRC analysis of immunoprecipitated DNA relative to the total input DNA for each
primer pair. We found that Zta induced ~200 fold increase in BrdU incorporation in EBV genome DNA (Fig. 8A) . In contrast, Zta expression reduced mitochondrial BrdU incorporation to ~61% and cellular actin BrdU incorporation ~57% of mock transfected cells (Fig. 8B ). To determine if Zta affected the copy number or stability of mitochondrial genomes, we assayed total cellular DNA 48 hrs after transfection with Zta into ZKO-293 cells (Fig. 8C) . We found that Zta transfection dramatically reduced mitochondrial DNA copy number (Fig. 8C , left panel.
Zta also reduced and altered the mobility of cellular Alu repeat DNA (Fig. 8C, middle panel) .
As expected, Zta increased the copy number of EBV genome DNA (Fig. 8C, right panel) . These data indicate that Zta inhibits mitochondrial DNA replication and decreases mitochondrial genome copy number while activating viral lytic replication (Fig. 8D ).
DISCUSSION
Our results indicate that mtSSB can be isolated in a stable complex with Zta during lytic cycle replication of EBV. mtSSB was isolated by biochemical purification of FLAG-tagged Zta expressed in ZKO-293 cells (Fig. 1) . FLAG-Zta protein efficiently activates transcription and lytic replication in ZKO-293 cells, and therefore is likely to associate with functionally significant cellular proteins. mtSSB associated with endogenous Zta in lymphoblastoid cells after lytic induction with TPA and NaB (Fig. 2) . The functional significance of these interactions were explored by several methods. siRNA depletion of mtSSB inhibited EBV lytic replication, but had modest effect on transcription activation of early viral antigens (Fig. 3) . A point mutation in Zta (C189S) that compromises replication function, disrupted the interaction of Zta with mtSSB (Fig. 4) . Overexpression of mtSSB stimulated lytic replication with wt Zta, but had no effect on Zta C189S (Fig. 4) . In contrast, mtSSB expression inhibited transcription
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activation of two viral promoters fused to reporter luciferase genes (Fig. 5) . This suggests that mtSSB may stimulate the replication function, but inhibit transcription activation. Based on these findings, we propose that mtSSB plays a role in switching Zta from a transcription activator to a replication protein during lytic cycle reactivation (Fig. 8D) .
The role of mtSSB in EBV lytic replication is not completely understood. mtSSB is a single stranded DNA binding protein with properties similar to E. coli SSB (12, 30) . mtSSB is a key component of the mitochondrial DNA replication machinery and is an essential gene in several organisms where this question has been examined (36, 46) . Like E. coli SSB, mtSSB stabilizes single strand formation and stimulates homologous strand exchange by RecA (15) .
Mitochondrial DNA replication initiates through a complex mechanism involving RNA transcription mediated priming and strand invasion to form a stable triple strand structure referred to as an R-loop (38, 47) . The precise role for mtSSB in the formation and resolution of these structures at mitochondrial origins of DNA replication is not completely elucidated.
The molecular mechanism of EBV lytic replication and the role of cellular factors in this process is not yet known. Some studies have implicated cellular proteins, like topoisomerases, as essential for herpesvirus lytic replication (5, 37) . At EBV OriLyt, several cellular DNA binding proteins have been implicated in the replication function (3, 54) . The DNA structure of the downstream element at OriLyt is non-B-DNA and readily unwound (39) . Recent studies also indicate that numerous RNA transcripts initiate within OriLyt (55) . In studies with the related gammaherpesvirus Kaposi's Sacrcoma Associated Herpesvirus (KSHV) RNA transcription initiation within Orilyt was found to be essential for efficient lytic replication (52) . Studies with cytomegalovirus (CMV) have found that RNA transcripts and RNA-hybrids exist at the lytic origin and these structures may reflect complex transcription related events during initiation of
lytic replication (25, 40) . Our experiments do not address whether mtSSB plays a similar role in replication initiation at EBV OriLyt as it does at mitochondrial DNA origins, or whether RNA transcripts contribute to EBV replication. However, the positive contribution of mtSSB to EBV lytic replication suggests that EBV and other herpesvirus lytic origins may share some common features with mitochondrial DNA replication origins.
A second major finding from these studies is that Zta-induced lytic replication led to a loss of mitochondrial DNA replication. Zta is known to inhibit cell cycle progression and nuclear DNA synthesis, but it has not been demonstrated that EBV lytic cycle blocks mitochondrial DNA replication. Inhibiting mitochondrial DNA replication may be expected based on our understanding of herpesvirus replication and their tendency to shut-off many hostcell metabolic pathways. Recent studies have found that HSV lytic infection leads to a nucleolytic degradation of mitochondrial DNA through the action of the viral-encoded nuclease UL12.5 (44) . A KSHV orthologue of UL12.5 was found to be important for degradation of host mRNA, although this functions was separable from the DNase functional domain (17) . More recent studies indicate that EBV orthologue BGLF5 can also eliminate host-cell immune function by selective degradation of cellular mRNA (18, 43) . The relationship between DNA and RNA nuclease activity and their potential roles in disruption of mitochondrial DNA stability remains unclear. We found that EBV lytic gene expression led to a loss of BrdU incorporation and a loss of mitochondrial DNA copy number (Fig. 8) . We did not detect any clear evidence of degraded mitochondrial genomes, but we can not exclude that a nuclease based mechanism for degradation of mitochondrial DNA also exists in EBV. The inhibition of mitochondrial DNA synthesis may be achieved through multiple mechanisms. Consistent with the findings reported here is the report that Zta expression alters mitochondrial morphology (28). We did not observe
a significant loss of mitochondrial DNA copy number after Zta transfection in EBV negative cells (data not shown), so it is likely that additional viral encoded lytic genes contribute to the loss of mitochondrial DNA synthesis and genome copy number. Future studies will be required to determine if the EBV orthologue of HSV UL12.5 also contributes to the loss of mitochondrial DNA copy number, or if EBV has acquired a different mechanism for achieving the same function. The interaction of Zta with mtSSB suggests that EBV has acquired a novel mechanism for disrupting cellular mitochondrial function, and pirated this protein for efficient replication of its own genome.
ACKNOWLEDGMENTS
We thank H. 
A C C E P T E D
